26.05.2010

U.S. Warns Perrigo Over Ongoing Manufacturing Lapses

Perrigo has repeatedly failed to correct multiple manufacturing violations at its Allegan, Mich., facility that have resulted in drug mix-ups and contamination, according to U.S. health regulators. Shares of the drug manufacturer and distributor fell 6% to $53.61 in early trading on the Nasdaq after the U.S. Food and Drug Administration (FDA) released its warning letter to the company citing the problems. more